Protalex, Inc. · New Hope, PA United States (OTC: PRTX)
| 145 Union Square Dr. | Phone: 215-862-9720 |
| New Hope, PA | Fax: 215-862-6614 |
| 18938 | |
| United States | 
Map This Company |
Protalex, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Protalex is developing a technique called bioregulation to make drugs that control a disease instead of treating the symptoms after the disease has wreaked havoc on the body. The company's development programs target autoimmune diseases and inflammatory ailments. Lead drug candidate PRTX-100 is in early stage trials to target rheumatoid arthritis and idiopathic thrombocytopenic purpura (ITP), an autoimmune disorder characterized by excessive bleeding. Other potential disease targets include skin diseases psoriasis and pemphigus, inflammatory bowel condition Crohn's disease, and autoimmune disorders multiple sclerosis and lupus.
Protalex, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: PRTX Single Location |
|---|---|
| Fiscal Year-End | May |
| 2011 Employees | 3 |
Executives
4 executives listed for Protalex, Inc.'s New Hope, PA location.
| President and Director | Arnold Kling | |
|---|---|---|
| CFO and Secretary | Kirk Warshaw |